India is trying to promote a temporary waiver on some sections of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement at the World Trade Organization (WTO), which is a move towards equitable access of vaccines and other medicines to everyone across the world, commerce and industry minister Piyush Goyal said on Wednesday.
Currently, the proposal initiated by India and South Africa is being discussed at the WTO and has been backed by over 100 countries. However, European Union and some other developed nations are not supporting the move. Major pharmaceutical companies have argued that the move can hurt innovation.
“It is unfortunate that some countries are putting profits over prudence...today is not the time even for pharma companies to count their dollars, today is the time for the world to work together...It is myopic strategy that some countries are following,” Goyal said at a virtual event.
Speaking at the India Global forum, the minister said that India is looking at a greater degree of engagement with countries that are ‘democratic in their political system’ and can ‘relate and trust as a partner’.
Towards this, India is working towards greater engagement with countries that believe in transparent rules-based trading mechanisms. India is currently talking to the UK, Australia, Canada and EU for trade deals, and is keen to speed them up.
“We are looking at investments, technology, high quality goods, equipment, machinery. We will be looking at providing high quality technology support to our services & IT sector,” he added.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU